# Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells

Alexis Broquet, Victor Gourain, Thomas Goronflot, Virginie Le Mabecque, Debajyoti Sinha, Mitra Ashayeripanah, Cédric Jacqueline, Pierre Martin, Marion Davieau, Lea Boutin, et al.

<figure><img src="image_1.png" /></figure>

## To cite this version:

Alexis Broquet, Victor Gourain, Thomas Goronflot, Virginie Le Mabecque, Debajyoti Sinha, et al.,

Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells. Nature Immunology, 2024, 25 (11), pp.2167-2167. 10.1038/s41590-024-02000-x. hal-05072818

HAL Id: hal-05072818

https://nantes-universite.hal.science/hal-05072818v1

Submitted on 28 May 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Author Correction: Sepsis-trained macrophages promote antitumoral tissue-resident T cells

Correction to: *Nature Immunology*

https://doi.org/10.1038/s41590-024-01819-8,
published online 29 April 2024.

https://doi.org/10.1038/s41590-024-02000-x

Published online: 7 October 2024

Alexis Broquet, Victor Gourain®, Thomas Goronflot, Virginie Le Mabecque, Debajyoti Sinha, Mitra Ashayeripanah, Cédric Jacqueline®, Pierre Martin, Marion Davieau, Lea Boutin, Cecile Poulain, Florian P. Martin, Cynthia Fourgeux, Melanie Petrier®, Manon Cannevet, Thomas Leclercq, Maeva Guillonneau®, Tanguy Chaumette®, Thomas Laurent®, Christelle Harly®, Emmanuel Scotet, Laurent Legentil, Vincent Ferrières, Stephanie Corgnac®, Fathia Mami-Chouaib®, Jean Francois Mosnier, Nicolas Mauduit, Hamish E. G. McWilliam®, Jose A. Villadangos®, Pierre Antoine Gourraud, Karim Asehnoue, Jeremie Poschmann® & Antoine Roquilly®

In the version of the article initially published, the support of LabEx IGO was not included in
the Acknowledgements and has now been added to the HTML and PDF versions of the article.

© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024

# Author Correction: GPR34 is a metabolic immune checkpoint for ILC1-mediated antitumor immunity

Correction to: *Nature Immunology*

https://doi.org/10.1038/s41590-024-01973-z,
published online 2 October 2024.

https://doi.org/10.1038/s41590-024-02001-w

Published online: 7 October 2024

Jiaxian Yan®, Chi Zhang®, Yueli Xu®, Zonghui Huang, Qingyuan Ye, Xiaojun Qian, Liang Zhu, Guangming Huang®, Xiaqiong Wang®, Wei Jiang® & Rongbin Zhou®

In the version of this article initially published, in the Fig. 2 legend, currently reading “GPR34 inhibits antitumor immunity by regulating ILC1s,” “inhibits” appeared as “promotes.” The changes have been made to the HTML and PDF versions of the article.

© The Author(s), under exclusive licence to Springer Nature America, Inc. 2024